BIOBV — Biohit Oyj Balance Sheet
0.000.00%
- €39.37m
- €33.25m
- €14.28m
- 71
- 26
- 74
- 60
Annual balance sheet for Biohit Oyj, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 6.08 | 5.51 | 6.23 | 6.81 | 6.71 |
Net Total Receivables | 1.32 | 2.72 | 2.75 | 4.13 | 3.21 |
Total Inventory | |||||
Total Other Current Assets | |||||
Total Current Assets | 8.3 | 8.98 | 9.9 | 11.8 | 11 |
Net Property, Plant And Equipment | 0.64 | 0.42 | 0.993 | 0.766 | 0.702 |
Net Intangible Assets | |||||
Long Term Investments | |||||
Long Term Notes Receivable | |||||
Other Long Term Assets | |||||
Total Assets | 10.8 | 9.61 | 11 | 12.9 | 15.5 |
Accounts Payable | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 1.94 | 2.15 | 2.86 | 3.06 | 3.02 |
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Deferred Income Tax | |||||
Total Other Liabilities | |||||
Total Liabilities | 2.07 | 2.31 | 3.56 | 3.49 | 3.31 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Unrealized Gain / Loss | |||||
Other Equity | |||||
Total Equity | 8.7 | 7.3 | 7.46 | 9.43 | 12.2 |
Total Liabilities & Shareholders' Equity | 10.8 | 9.61 | 11 | 12.9 | 15.5 |
Total Common Shares Outstanding |